about
Clinical and cost effectiveness of paclitaxel, docetaxel, gemcitabine, and vinorelbine in non-small cell lung cancer: a systematic reviewA phase II study of sequential chemotherapy with docetaxel after the weekly PELF regimen in advanced gastric cancer. A report from the Italian group for the study of digestive tract cancerAntineoplastic agents from natural sources: achievements and future directions.Phase II study of docetaxel in patients with metastatic pancreatic cancer: a Japanese cooperative study. Cooperative Group of Docetaxel for Pancreatic Cancer in JapanNeoadjuvant docetaxel for operable breast cancer induces a high pathological response and breast-conservation rate.Comparative benefits of Nab-paclitaxel over gemcitabine or polysorbate-based docetaxel in experimental pancreatic cancerEpiphora in lung cancer patients receiving docetaxel: a case series.Natural product drug discovery in the next millennium.Anticancer Chemotherapy and it's Anaesthetic Implications (Current Concepts)Short post-infusion scalp cooling time in the prevention of docetaxel-induced alopecia.Benefit risk assessment and update on the use of docetaxel in the management of breast cancer.A phase I clinical trial of dose escalation of lobaplatin in combination with fixed-dose docetaxel for the treatment of human solid tumours that had progressed following chemotherapyDocetaxel, cisplatin and fluorouracil (DCF) regimen compared with non-taxane-containing palliative chemotherapy for gastric carcinoma: a systematic review and meta-analysisInteractions of antimitotic peptides and depsipeptides with tubulin.Docetaxel-loaded pluronic p123 polymeric micelles: in vitro and in vivo evaluation.Contribution of hepatic organic anion-transporting polypeptides to docetaxel uptake and clearanceDevelopment of Polysorbate 80/Phospholipid mixed micellar formation for docetaxel and assessment of its in vivo distribution in animal models.Docetaxel: an alternative taxane in ovarian cancer.Docetaxel in the management of ovarian cancer.The role of docetaxel in the treatment of non-small cell lung cancer lung cancer: an update.Gemcitabine in metastatic breast cancer.A critical review of lipid-based nanoparticles for taxane delivery.Docetaxel for the post-surgery treatment of patients with node-positive breast cancerWeekly docetaxel in the treatment of metastatic breast cancer.Paraclinical evaluation of side-effects of Taxanes on auditory systemPreparation, characterization and pharmacokinetics of folate receptor-targeted liposomes for docetaxel delivery.Oil-filled lipid nanoparticles containing 2'-(2-bromohexadecanoyl)-docetaxel for the treatment of breast cancerMechanistic Study of Inhibitory Effects of Atorvastatin and Docetaxel in Combination on Prostate Cancer.Solid lipid nanoparticle formulations of docetaxel prepared with high melting point triglycerides: in vitro and in vivo evaluation.Lethal Clostridium difficile Colitis Associated with Paclitaxel and Carboplatin Chemotherapy in Ovarian Carcinoma: Case Report and Review of the Literature.Current development in nanoformulations of docetaxel.Overcoming docetaxel resistance in prostate cancer: a perspective review.Custirsen (OGX-011): clusterin inhibitor in metastatic prostate cancer.Advances in the formulations of non-injection administration of docetaxel.Re-visiting Hypersensitivity Reactions to Taxanes: A Comprehensive Review.Results of 20- versus 45-min post-infusion scalp cooling time in the prevention of docetaxel-induced alopecia.A pH-responsive carboxymethyl dextran-based conjugate as a carrier of docetaxel for cancer therapy.Radiosensitization of TPGS-emulsified docetaxel-loaded poly(lactic-co-glycolic acid) nanoparticles in CNE-1 and A549 cells.Development and optimization of oil-filled lipid nanoparticles containing docetaxel conjugates designed to control the drug release rate in vitro and in vivo.Dermatological adverse events with taxane chemotherapy.
P2860
Q24678961-9C1CC835-CF04-4E4D-A333-D1FBE2061A95Q28350903-95747E71-A45B-4C9D-9D49-AC543BB5E28EQ30659806-C319F569-447D-4EA1-84B8-0D3D8BE6ABFDQ33329495-D881BCC8-4613-407D-B323-BBDEF1156689Q33348234-43B83272-E96A-4E94-B639-921CB375A79AQ33621256-6750053B-E5FF-44DA-AB8C-2C3915074EFFQ33713282-B8A55A8A-A72B-4E2D-AC88-832F723FB634Q33893121-A99E9F83-D7B5-497E-834D-DAB12890635EQ33974943-BBD41211-8955-496F-882F-DC6F5B697436Q34271252-148F5416-E4F6-434D-887D-C1B95E5AF803Q34379034-4ECCE090-C14D-420C-B5E5-A39BC84F375AQ34583261-3B8DD041-4170-4C2E-993D-67F7DCB85846Q34672942-22161E6E-BBE8-4C46-8E6B-E12623ADA230Q34972878-6BCE012F-88D7-4445-9B02-0299D3A0A2E5Q35036060-6BFB1DEF-B7F8-4092-A60D-D970168A987CQ35375045-359752CD-9A81-4A72-823E-D22B3DB1A041Q35537059-7522B025-E943-4E93-BEEA-F436BE559F06Q35602177-09D4B5CB-6911-4C15-B376-75F31A608B64Q36118370-4742FE73-879F-4450-9155-3C0984570A17Q36142491-14DCFDC5-3A26-4563-9B20-6BD6B213DB2BQ36185611-FCFDABA4-103A-4E06-97F8-A1DA36BEA842Q36360764-5BEA0AB9-612E-4AD1-B058-196F8249501FQ36823602-93B3A0D1-7009-43CC-9658-AEE1F9965BD2Q37052871-F770C91C-94AB-4F0F-BDEC-BA25591B9C50Q37210226-1907ADCE-1C1B-4AD1-B706-44509F389A77Q37251547-4F9E6C04-2AD4-48A0-8EC3-E9E33420E6ACQ37381382-D6997F7F-6C1C-4550-8231-6F7074A12639Q37547305-2FD107C6-153A-40E7-A510-C6A635AA1861Q37714256-945C2819-CDAC-4924-B298-EA3088800C81Q37779742-791C327C-891B-479C-A8A2-61DE9D5BADAFQ38019047-E158491F-BCC4-4E20-8CFF-3E05C6D62CE3Q38057235-F338C4C4-58E6-44D4-890E-DC21ABB83479Q38069776-10BE893F-80EE-4CA8-BA7A-7AB930EE0CE0Q38149881-2ACE3AE3-CE6C-4FA6-ADA1-9ADC46E3AD23Q38205153-425B0BB4-373C-4426-91DB-70D1902CE6F0Q38396811-FB5DCFD7-92C6-4E81-AE4F-A2FB21DF1973Q38810269-41FC05A4-5A8B-4F1A-9873-DD951E9CBA36Q38816559-6D7CC107-0E20-49DE-9081-2C3BB16F1689Q38885649-5339127D-FD44-429E-9C1F-5E2EFC6AF79CQ38934447-F15DBF29-2631-4084-9C3A-CA16C3128105
P2860
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年学术文章
@wuu
1995年学术文章
@zh-cn
1995年学术文章
@zh-hans
1995年学术文章
@zh-my
1995年学术文章
@zh-sg
1995年學術文章
@yue
1995年學術文章
@zh
1995年學術文章
@zh-hant
name
Docetaxel.
@en
type
label
Docetaxel.
@en
prefLabel
Docetaxel.
@en
P1476
Docetaxel.
@en
P2093
P304
P356
10.1200/JCO.1995.13.10.2643
P407
P577
1995-10-01T00:00:00Z